Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Soudeh Ghafouri‐Fard, Atefe Abak, Farhad Tondro Anamag, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165
5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy
Anai A. Valencia-Lazcano, Dilawar Hassan, Mehrab Pourmadadi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114995-114995
Closed Access | Times Cited: 84
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?
Mohamed Salla, Nadine Karaki, Belal El Kaderi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 569-569
Open Access | Times Cited: 24
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Dzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 208-208
Open Access | Times Cited: 39
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
Chronotherapy in Glioblastoma: state of the art and future perspectives
Marina Petković, Melad Henis, Oliver Heese, et al.
EBioMedicine (2023) Vol. 89, pp. 104470-104470
Open Access | Times Cited: 27
The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 27
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
William H. Gmeiner, Charles Chidi Okechukwu
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 257-272
Open Access | Times Cited: 25
Comprehensive Insights into Oral Squamous Cell Carcinoma: Diagnosis, Pathogenesis, and Therapeutic Advances
Dharshini Jagadeesan, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155489-155489
Closed Access | Times Cited: 10
Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer
Chunge Zhong, Shengnan Wang, Wenjie Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Cerium oxide decorated 5-fluorouracil loaded chitosan nanoparticles for treatment of hepatocellular carcinoma
Anbazhagan Sathiyaseelan, Kandasamy Saravanakumar, Myeong‐Hyeon Wang
International Journal of Biological Macromolecules (2022) Vol. 216, pp. 52-64
Closed Access | Times Cited: 31
Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer
Mohammad Habeeb, Huay Woon You, Kiran Balasaheb Aher, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104487-104487
Closed Access | Times Cited: 19
Design and fabrication of a novel platform for detection of 5-fluorouracil as the anti-cancer drug using COFs/MOFs nanocomposite with graphene quantum dotes
Biuck Habibi, Sara Pashazadeh
Microchemical Journal (2024), pp. 111657-111657
Closed Access | Times Cited: 8
One‐Pot Synthesis of Luminescent and Photothermal Carbon Boron‐Nitride Quantum Dots Exhibiting Cell Damage Protective Effects
Grazia M. L. Consoli, Ludovica Maugeri, Nicolò Musso, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 7
αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment
Prashant Pandey, Dilip Kumar Arya, Payal Deepak, et al.
Bioengineering (2024) Vol. 11, Iss. 8, pp. 800-800
Open Access | Times Cited: 6
The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance
Mohammad H. Ghazimoradi, Sadegh Babashah
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma
Ahsan Ali, Asadullah Madni, Hassan Shah, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281004-e0281004
Open Access | Times Cited: 16
Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
Ignatios Ioakeim‐Skoufa, Natalia Tobajas-Ramos, Enrica Menditto, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2972-2972
Open Access | Times Cited: 14
Anti-Tumor Efficacy of Oleuropein-Loaded ZnO/Au Mesoporous Silica Nanoparticle in 5-FU-Resistant Colorectal Cancer Cells
Sang Mi Park, Da Yeon Kim, Kyeong Hyeon Lee, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2675-2690
Open Access | Times Cited: 5
P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
Gazmend Temaj, Silvia Chichiarelli, Pelin Telkoparan‐Akillilar, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116332-116332
Closed Access | Times Cited: 5
The role of LncRNA-mediated autophagy in cancer progression
Zi-Yuan Liu, Jiaming Tang, Meng-Qi Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Advancements of Gene Therapy in Cancer Treatment: A Comprehensive Review
Muhammad Dhiyauddin Mohd Abas, Muhammad Fareez Mohd Asri, Nur Anis Suffiah Yusafawi, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155509-155509
Closed Access | Times Cited: 5
Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: An evidence-based hypothesis
Hassan Akbari, Farzad Taghizadeh‐Hesary, Moslem Bahadori
Mitochondrion (2021) Vol. 62, pp. 151-158
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top